Best Stocks: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), JetBlue Airways Corporation (NASDAQ:JBLU), First Midwest Bancorp Inc. (NASDAQ:FMBI), Prothena Corporation plc (NASDAQ:PRTA), RCI Hospitality (NASDAQ:RICK)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 297,968 shares at the public offering price of $110.75 per share. The exercise of the over-allotment option brought the total number of shares of common stock sold by Agios to 2,284,423 shares and increased the amount of gross proceeds raised in the offering, before underwriting discounts and estimated expenses of the offering, to approximately $253 million. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) belongs to Healthcare sector. Its net profit margin is -82.60% and weekly performance is -2.79%. On last trading day company shares ended up $107.47. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) distance from 50-day simple moving average (SMA50) is 25.84%.

JetBlue Airways (NASDAQ:JBLU) was the target of a large drop in short interest in November. As of November 28th, there was short interest totalling 44,292,300 shares, a drop of 8.3% from the November 14th total of 48,297,103 shares, AR Network reports. JetBlue Airways Corporation (NASDAQ:JBLU) shares decreased -3.35% in last trading session and ended the day at $14.44. JBLU Gross Margin is 51.40% and its return on assets is 4.70%. JetBlue Airways Corporation (NASDAQ:JBLU) quarterly performance is 28.93%.

First Midwest Bancorp Inc. (NASDAQ:FMBI) begin trading ex-dividend on December 17, 2014. A cash dividend payment of $0.08 per share is scheduled to be paid on January 13, 2015. On 16 December, First Midwest Bancorp Inc. (NASDAQ:FMBI) shares increased 0.06% and was closed at $16.56. FMBI EPS growth in last 5 year was 1.20%. First Midwest Bancorp Inc. (NASDAQ:FMBI) year to date (YTD) performance is -4.22%.

Prothena Corporation plc (NASDAQ:PRTA), announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to NEOD001, a novel monoclonal antibody for the potential treatment of AL amyloidosis. Prothena Corporation plc (NASDAQ:PRTA) ended the last trading day at $18.50. Company weekly volatility is calculated as 7.07% and price to cash ratio as 1.65. Prothena Corporation plc (NASDAQ:PRTA) showed a weekly performance of -9.93%.

RCI Hospitality Holdings, Inc. (NASDAQ:RICK) announced results for the fiscal 2014 fourth quarter and year ended September 30, 2014. GAAP EPS diluted of $0.42 compared to $0.17, an increase of more than 147%. 4Q14 included the benefit of a gain on contractual reduction of debt, partially offset by an asset impairment charge related to the subsequent sale of a one adult club and the closing of another. RCI Hospitality Holdings, Inc. (NASDAQ:RICK) shares increased 0.53% in last trading session and ended the day at $9.53. RICK Gross Margin is 65.30% and its return on assets is 7.80%. RCI Hospitality Holdings, Inc. (NASDAQ:RICK) quarterly performance is -17.13%.